NASDAQ:RDEA - Ardea Biosciences Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
Previous CloseN/A
Today's RangeN/A
52-Week RangeN/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Ardea Biosciences, Inc. (Ardea) is a biotechnology company focused on the development of small-molecule therapeutics for the treatment of serious diseases. The Company's product portfolio includes Lesinurad (RDEA594), RDEA3170 and BAY 86-9766 (RDEA119). Lesinurad (RDEA594) is an inhibitor of the URAT1 kidney transporter for the treatment of gout. RDEA3170 is a URAT1 kidney transporter inhibitors for the treatment of gout. BAY 86-9766 (RDEA119) is a MEK inhibitor for the treatment of cancer. On June 19, 2012, AstraZeneca PLC acquired the Company.

Receive RDEA News and Ratings via Email

Sign-up to receive the latest news and ratings for RDEA and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
Current SymbolNASDAQ:RDEA
CUSIPN/A
Phone+1-858-6526500

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
OptionableNot Optionable

Ardea Biosciences (NASDAQ:RDEA) Frequently Asked Questions

What is Ardea Biosciences' stock symbol?

Ardea Biosciences trades on the NASDAQ under the ticker symbol "RDEA."

Has Ardea Biosciences been receiving favorable news coverage?

News stories about RDEA stock have trended positive on Tuesday, InfoTrie Sentiment Analysis reports. The research group scores the sentiment of press coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Ardea Biosciences earned a news sentiment score of 2.3 on InfoTrie's scale. They also assigned news coverage about the biotechnology company a news buzz of 6.0 out of 10, indicating that recent press coverage is somewhat likely to have an impact on the company's share price in the next several days.

How do I buy shares of Ardea Biosciences?

Shares of RDEA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Ardea Biosciences' official website?

The official website for Ardea Biosciences is http://www.ardeabio.com/.

How can I contact Ardea Biosciences?

Ardea Biosciences' mailing address is 4939 Directors Pl, SAN DIEGO, CA 92121-3829, United States. The biotechnology company can be reached via phone at +1-858-6526500.


MarketBeat Community Rating for Ardea Biosciences (NASDAQ RDEA)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  80 (Vote Outperform)
Underperform Votes:  75 (Vote Underperform)
Total Votes:  155
MarketBeat's community ratings are surveys of what our community members think about Ardea Biosciences and other stocks. Vote "Outperform" if you believe RDEA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RDEA will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/19/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel